Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2010
12/29/2010EP2267445A1 Methods of detecting small intestinal bacterial overgrowth (SIBO) in a human subject
12/29/2010EP2267117A2 Differentiation modulating agents and uses therefor
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2267023A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267022A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267021A2 KDR peptides and vaccines comprising the same
12/29/2010EP2266989A2 Heterocyclic derivatives
12/29/2010EP2266983A1 Nitrogenated 5-membered heterocyclic compound
12/29/2010EP2266962A1 The compounds as the estrogen related receptors modulators and the uses thereof
12/29/2010EP2266946A2 Compound For The Treatment Of Metabolic Disorders
12/29/2010EP2266665A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention
12/29/2010EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/29/2010EP2266576A1 Treatment of diabetes with thiazolidinedione and sulphonylurea
12/29/2010EP2266569A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
12/29/2010EP2266566A2 Nicotinamide derivatives and their use as therapeutic agents
12/29/2010EP2266560A1 Benzothiophenes, formulations containing same, and methods
12/29/2010EP2266540A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor
12/29/2010EP2265588A1 INHIBITORS OF 11ß -HYDROXYSTEROID DEHYDROGENASE TYPE 1
12/29/2010EP2265281A2 Use of interleukin-1 conjugates in the treatment of diabetes
12/29/2010EP2265278A1 A composition for treatment and improvement of diabetes comprising caveolin as active ingredient and a method for treatment of diabetes using it
12/29/2010EP2265271A1 Crystalline 2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide
12/29/2010EP2265119A1 Fungicide hydroximoyl-tetrazole derivatives
12/29/2010EP1689415B1 Improving iron uptake
12/29/2010EP1530568B1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
12/29/2010EP1529062B1 Therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
12/29/2010EP1438052B1 Quinazolin-4-ones as inhibitors of human phosphatidylinositol 3-kinase delta
12/29/2010EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/29/2010CN1968691B Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
12/29/2010CN1922139B Bicyclic amide derivatives
12/29/2010CN1908156B Monascus novel strain and traditional Chinese medicine monascus prepared by fermenting the same
12/29/2010CN1902196B Thiazole derivative
12/29/2010CN1899361B Zhenqi medicinal composition and its preparation
12/29/2010CN1682737B Compound dimethylbiguanide/glipizide control release tablet and preparing method
12/29/2010CN101932719A Branched -glucan, -glucosyltransferase producing the same, method for producing the same and use thereof
12/29/2010CN101932607A Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
12/29/2010CN101932576A Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as dgat1 inhibitors
12/29/2010CN101932562A Carbamoyl compounds as dgat1 inhibitors 190
12/29/2010CN101932557A Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
12/29/2010CN101932321A Combination therapy comprising sglt inhibitors and dpp4 inhibitors
12/29/2010CN101932314A New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin
12/29/2010CN101932311A Microparticles and pharmaceutical compositions thereof
12/29/2010CN101928745A Preparation method and applications of ant polypeptide
12/29/2010CN101928739A New preparation method of high-density lipoprotein
12/29/2010CN101928655A Schisandra chinensis health protection wine and preparation method thereof
12/29/2010CN101928329A Tripeptide boric acid (ester) compound and preparation method and application thereof
12/29/2010CN101928320A American ginseng ginsenoside F5ab and extraction method and medicinal application thereof
12/29/2010CN101928259A 2-arylthiazole derivative and medicament composition thereof
12/29/2010CN101928244A Structural analogue and derivative of isochromanone-4 compound with cardiovascular activity, preparation method and application thereof
12/29/2010CN101928241A 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them
12/29/2010CN101928213A Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom
12/29/2010CN101926997A Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity
12/29/2010CN101926979A Use of fungal immunomodulatory protein
12/29/2010CN101926959A Chinese medicinal herbal preparation for preventing and treating stroke, adjusting blood fat and relaxing bowels
12/29/2010CN101926942A Glucose-lowering health care medicinal tea and preparation method thereof
12/29/2010CN101926899A Health-care medicament for hyperlipemia and preparation method thereof
12/29/2010CN101926898A Plaque removing and fixing tablet for treating unstable carotid plaque
12/29/2010CN101926891A Composition for losing weight
12/29/2010CN101926872A Chinese medicinal detoxifying myo-regeneration paste for treating diabetic foot ulcer and preparation method thereof
12/29/2010CN101926853A Medicine composition with function of lowering blood sugar level as well as preparation method and application thereof
12/29/2010CN101926843A Quality control method of Xinnaoqing soft capsules
12/29/2010CN101926841A Total flavonoids of herba lycopi in botanical medicine for treating cardiovascular disease and preparation method thereof
12/29/2010CN101926839A Synthesis method of green vitamins
12/29/2010CN101926817A Application of Soracan gum in reducing liver fat, blood fat, body fat, body weight and cholesterol
12/29/2010CN101926807A Fructose combination medicament
12/29/2010CN101926803A Application of quinazoline compounds
12/29/2010CN101926802A Application of quinazoline compounds
12/29/2010CN101926788A Cardiovascular/cerebral and ophthalmological medicines, and preparation and use thereof
12/29/2010CN101926761A Production method of compound potassium dihydrogn phosphate
12/29/2010CN101543621B Drug for curing diabetes
12/29/2010CN101468149B Quick-effective hypoglycemic Chinese medicine preparation
12/29/2010CN101417132B Use of medicine combination comprising carvedilol and angiotensin II recipient antagonist in preparing medicine for treating kidney disease
12/29/2010CN101396468B Traditional Chinese medicine for treating diabetes coronary heart disease
12/29/2010CN101396357B Use of lipoamide in preventing and treating insulin resistance
12/29/2010CN101347171B Freezing beverage containing chrysanthemum and method of preparing the same
12/29/2010CN101336904B Acarbose chewable tablets and preparation method thereof
12/29/2010CN101327204B Use of emodic acid in preventing and treating fatty liver
12/29/2010CN101259191B Fat-reducing health products and producing method thereof
12/29/2010CN101212976B Visceral fat accumulation inhibitor
12/29/2010CN101117348B A and C macrocyclic oxidation substituted pentacyclic triterpanoids and preparation method and use thereof
12/29/2010CN101098702B Drugs, food or drink for improving pancreatic functions
12/29/2010CN101057661B Extraction method for alpha-linolenic acid and preparation
12/29/2010CN101052400B Application of pyridine compound for preparing medicine for curing injured skin
12/29/2010CA2766387A1 Novel thiophenecarboxamide derivative and pharmaceutical use thereof
12/29/2010CA2766154A1 Novel fumarate salts of a histamine h3 receptor antagonist
12/29/2010CA2765992A1 Fish protein hydrolysate for use thereof in inhibiting weight gain and/or weight loss
12/29/2010CA2765560A1 Mutation that increases the oleic acid content in soybean oil and responsible gene thereof
12/29/2010CA2765108A1 Truncated actriib-fc fusion proteins
12/29/2010CA2764475A1 Crystals
12/29/2010CA2764423A1 Preparation comprising insulin, nicotinamide and an amino acid
12/28/2010USRE42014 Pharmaceutical compositions
12/28/2010US7858820 Easy to process and are highly stable on storage; nutraceuticals; dietetics; anions of inner salts contribute to therapeutic and nutritional value of compound; human and animal food/feed supplement; dosage
12/28/2010US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes
12/28/2010US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes
12/28/2010US7858617 2-hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one; inhibition of a lipase, esterase or phosphatase enzyme
12/28/2010US7858577 Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2
12/28/2010US7858128 preparing potassium calcium hydroxycitric acid from plant extract of the rind of Garcinia fruit; nutraceuticals for dietetics
12/28/2010US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
12/28/2010US7858085 Reducing blood glucose level in a non-obese or obese human afflicted with Type 2 diabetes by administering purified human placental alkaline phosphatase
12/23/2010WO2010148253A2 Formulations for lysosomal enzymes
12/23/2010WO2010148042A1 Oxabicyclo [4.1.o]hept-b-en-s-ylcarbamoyl derivatives inhibiting the nuclear factor-kappa(b) - (nf-kb)
1 ... 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 ... 1298